Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H Liang

Showing results (1-10 of 270) with videos related to

Pageof 27
Sort By:
ACS Medicinal Chemistry Letters|July 16, 2025
Novel Heterocyclic 5<i>H</i>‑Dibenzo[b,f]azepine Derivatives as Selective HDAC6 Inhibitors for Treatment of Charcot Marie Tooth DiseaseSteven H Liang
American Journal of Nuclear Medicine and Molecular Imaging|November 24, 2025
PARP-targeted molecular imaging for noninvasive diagnosis and surgical guidance in basal cell carcinomaSteven H Liang
American Journal of Nuclear Medicine and Molecular Imaging|November 24, 2025
From lutetium to terbium: a new era in PSMA-targeted radioligand therapy for mCRPC patientsSteven H Liang
ACS Medicinal Chemistry Letters|September 17, 2025
Chelator Optimization and Therapeutic Potential of <sup>188</sup>Re-FAPI for FAP-Targeted Radionuclide TherapySteven H Liang
Acta Pharmaceutica Sinica. B|May 25, 2026
Hypoxia-selective targeting of eEF1A1: A promising therapeutic strategy for triple-negative breast cancerSteven H Liang
American Journal of Nuclear Medicine and Molecular Imaging|July 21, 2025
Trop2-targeted immunoPET ligandsSteven H Liang
ACS Medicinal Chemistry Letters|November 19, 2025
Novel <i>N</i>‑Arylquinoline-4-carboxamide Derivatives as Prostaglandin F Receptor AntagonistsSteven H Liang
American Journal of Nuclear Medicine and Molecular Imaging|November 24, 2025
DLL3-targeted immunoPET and radioimmunotherapy ligandsSteven H Liang
ACS Medicinal Chemistry Letters|November 19, 2025
Novel N‑(Pyridin-3-yl)benzamide Derivatives as Histone Acyl Transferase Positive ModulatorsSteven H Liang
ACS Medicinal Chemistry Letters|October 15, 2025
Development of Novel PET Tracers for Imaging Non-AD TauopathiesSteven H Liang
Pageof 27

Showing results (1-10 of 270) with videos related to

Sort By:
Pageof 27
ACS Medicinal Chemistry Letters|July 16, 2025
Novel Heterocyclic 5<i>H</i>‑Dibenzo[b,f]azepine Derivatives as Selective HDAC6 Inhibitors for Treatment of Charcot Marie Tooth DiseaseSteven H Liang
American Journal of Nuclear Medicine and Molecular Imaging|November 24, 2025
PARP-targeted molecular imaging for noninvasive diagnosis and surgical guidance in basal cell carcinomaSteven H Liang
American Journal of Nuclear Medicine and Molecular Imaging|November 24, 2025
From lutetium to terbium: a new era in PSMA-targeted radioligand therapy for mCRPC patientsSteven H Liang
ACS Medicinal Chemistry Letters|September 17, 2025
Chelator Optimization and Therapeutic Potential of <sup>188</sup>Re-FAPI for FAP-Targeted Radionuclide TherapySteven H Liang
Acta Pharmaceutica Sinica. B|May 25, 2026
Hypoxia-selective targeting of eEF1A1: A promising therapeutic strategy for triple-negative breast cancerSteven H Liang
American Journal of Nuclear Medicine and Molecular Imaging|July 21, 2025
Trop2-targeted immunoPET ligandsSteven H Liang
ACS Medicinal Chemistry Letters|November 19, 2025
Novel <i>N</i>‑Arylquinoline-4-carboxamide Derivatives as Prostaglandin F Receptor AntagonistsSteven H Liang
American Journal of Nuclear Medicine and Molecular Imaging|November 24, 2025
DLL3-targeted immunoPET and radioimmunotherapy ligandsSteven H Liang
ACS Medicinal Chemistry Letters|November 19, 2025
Novel N‑(Pyridin-3-yl)benzamide Derivatives as Histone Acyl Transferase Positive ModulatorsSteven H Liang
ACS Medicinal Chemistry Letters|October 15, 2025
Development of Novel PET Tracers for Imaging Non-AD TauopathiesSteven H Liang
Pageof 27